Auna S.A. (NYSE:AUNA – Get Free Report) Director John Wilton sold 17,574 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $4.17, for a total value of $73,283.58. Following the completion of the transaction, the director owned 49,974 shares in the company, valued at approximately $208,391.58. The trade was a 26.02% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Auna Trading Up 0.2%
AUNA opened at $4.51 on Thursday. Auna S.A. has a one year low of $4.09 and a one year high of $6.85. The company has a market cap of $333.56 million, a P/E ratio of 17.34 and a beta of 0.81. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.00 and a current ratio of 1.09. The business’s 50-day simple moving average is $5.15 and its 200-day simple moving average is $5.01.
Auna (NYSE:AUNA – Get Free Report) last released its quarterly earnings data on Friday, May 15th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.14). Auna had a net margin of 1.53% and a return on equity of 16.25%. The business had revenue of $336.84 million during the quarter, compared to analysts’ expectations of $320.54 million. As a group, equities research analysts expect that Auna S.A. will post 0.81 EPS for the current fiscal year.
Institutional Trading of Auna
Wall Street Analyst Weigh In
A number of research analysts have recently commented on AUNA shares. Weiss Ratings reiterated a “sell (d)” rating on shares of Auna in a report on Friday, March 27th. JPMorgan Chase & Co. dropped their price objective on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Wall Street Zen downgraded Auna from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 16th. Finally, Zacks Research downgraded Auna from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 31st. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Auna has a consensus rating of “Hold” and a consensus price target of $6.97.
Read Our Latest Analysis on AUNA
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
See Also
- Five stocks we like better than Auna
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
